University of Manitoba receives ‘groundbreaking’ funding for vaccine, biomanufacturing research
Manitoba’s largest university is getting help to research vaccines. EU of M, along with the University of Alberta, Saskatchewan and Calgary are receiving $57 million to conduct vaccine bio manufacturing research as well as training for their delivery. 2 new facilities are set to be built on the Fort Gary and Bannatyne campuses for the research. Infectious diseases expert Jason Kindred Chuck says it means Manitoba has to no longer be as reliant on federal laboratories. So this has been you were a bit of a you know long standing creation with with our department and through the university. It really is to provide us with that capacity did to be responsive. You know whether we’re talking about SARS Co V2, we’re talking about monkeypox virus, we’re talking about H5 N 1 which obviously is a big concern in agriculture in the US right now. It puts us in the driver’s seat for diagnostics, vaccine development, therapeutic development, all those things that that we need to have in hand in Canada.